Format

Send to

Choose Destination
Nanomedicine (Lond). 2010 Jun;5(4):555-62. doi: 10.2217/nnm.10.29.

Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.

Author information

1
Nanotechnology Characterization Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD 21702, USA. marina@mail.nih.gov

Abstract

Nanotechnology is finding increasing application in biology and medicine. As with other pharmaceutical formulations and medical devices intended for use in animals and human patients, contamination of nanoparticles with bacterial endotoxins should be thoroughly investigated before preclinical in vitro and in vivo characterization. Traditional methods to study endotoxin contamination include the in vitro quantitative Limulus Amebocyte Lysate test and the in vivo qualitative rabbit pyrogen test. Both of these tests have a long history of use for traditional pharmaceuticals and medical devices and are routinely used in drug development. Here we report that nanoparticles often interfere with these traditional endotoxin detection tests and suggest approaches to detect and overcome such interferences.

PMID:
20528451
PMCID:
PMC2900157
DOI:
10.2217/nnm.10.29
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center